Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia (NCT00003861)

🧪 Interventions in This Study

• laboratory biomarker analysis (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (51 Sites)

Showing the first 25 of 51 sites.

• Naval Medical Center - San Diego — San Diego, California
• UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
• Tunnell Cancer Center at Beebe Medical Center — Lewes, Delaware
• CCOP - Christiana Care Health Services — Newark, Delaware
• Florida Hospital Cancer Institute at Florida Hospital Orlando — Orlando, Florida
• University of Illinois Cancer Center — Chicago, Illinois
• University of Chicago Cancer Research Center — Chicago, Illinois
• Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa
• Harold Alfond Center for Cancer Care — Augusta, Maine
• CancerCare of Maine at Eastern Maine Medical Center — Bangor, Maine
• Maine Center for Cancer Medicine and Blood Disorders - Scarborough — Scarborough, Maine
• Greenebaum Cancer Center at University of Maryland Medical Center — Baltimore, Maryland
• Union Hospital of Cecil County — Elkton, Maryland
• Massachusetts General Hospital — Boston, Massachusetts
• Dana-Farber/Brigham and Women's Cancer Center — Boston, Massachusetts
• Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute — Boston, Massachusetts
• Masonic Cancer Center at University of Minnesota — Minneapolis, Minnesota
• Ellis Fischel Cancer Center at University of Missouri - Columbia — Columbia, Missouri
• Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis — St Louis, Missouri
• University Medical Center of Southern Nevada — Las Vegas, Nevada
• CCOP - Nevada Cancer Research Foundation — Las Vegas, Nevada
• Cancer Institute of New Jersey at Cooper - Voorhees — Voorhees Township, New Jersey
• Roswell Park Cancer Institute — Buffalo, New York
• CCOP - Hematology-Oncology Associates of Central New York — East Syracuse, New York
• Queens Cancer Center of Queens Hospital — Jamaica, New York

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Leukemia

• AZD6738 for Patients With Progressive MDS or CMML — Boston, Massachusetts
• Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies — Philadelphia, Pennsylvania
• Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 — New York, New York
• Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL — Chicago, Illinois
• Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors — Memphis, Tennessee

Explore by condition: All Leukemia clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.